Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial - Hallek, M; Fischer, K; Fingerle-Rowson, G (Lancet, 2010)
et al.